Siu Christine

CIK 00017430292 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001743029

Recent Transactions

46 trades

Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-06-13+30,700→ 30,700 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-12+22,100→ 22,100 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-06-14+20,500→ 20,500 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-06-15+15,000→ 15,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-04-12+7,081→ 7,081 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-09$60.05/sh−901→ 36,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-12-09$0.59/sh+10,000→ 46,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-09$59.62/sh−9,099→ 37,371 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-12-09−10,000→ 152,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-12-04−10,000→ 162,191 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-04$58.60/sh−8,800→ 37,670 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-12-04$0.59/sh+10,000→ 46,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-04$59.39/sh−1,200→ 36,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-03$58.95/sh−5,400→ 40,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-12-03−10,000→ 172,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-12-03$0.59/sh+10,000→ 46,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-03$57.82/sh−600→ 45,870 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-03$59.65/sh−4,000→ 36,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-11-22$55.29/sh−601→ 36,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-11-22$0.59/sh+10,000→ 46,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-11-22$54.71/sh−9,399→ 37,071 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-11-21−10,000→ 182,191 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-11-21$55.12/sh−24,800→ 36,670 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-11-21$56.00/sh−200→ 36,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-11-21$0.59/sh+25,000→ 61,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-11-21−25,000→ 192,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-07-10−5,000→ 217,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-07-10$0.59/sh+5,000→ 41,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-07-10$39.37/sh−5,000→ 36,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-06-26−17,000→ 222,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-06-26$0.59/sh+17,000→ 36,470 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-06-05$29.34/sh−3,279→ 33,191 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-06-05$30.10/sh−13,421→ 19,770 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-06-05$31.03/sh−300→ 19,470 total
Award
Eidos Therapeutics, Inc.
Common Stock
2019-05-31$12.01/sh+1,769→ 36,470 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-04-24−5,000→ 239,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-04-24$0.59/sh+5,000→ 39,701 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-04-24$26.11/sh−5,000→ 34,701 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-03-19$0.15/sh+10,871→ 11,952 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-03-19−10,871→ 0 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-03-19$19.66/sh−11,913→ 34,701 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-03-19−34,662→ 244,191 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2019-03-19$0.59/sh+34,662→ 46,614 total
Award
Eidos Therapeutics, Inc.
Common Stock
2018-11-30$12.01/sh+1,081→ 1,081 total
Award
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2018-11-05+55,000→ 55,000 total

Companies

Recent Filings

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov